ILK-IN-1 is primarily used in biochemical research to study the role of integrin-linked kinase (ILK) in cellular processes. It serves as a potent and selective inhibitor of ILK, enabling researchers to investigate its involvement in cell adhesion, migration, and signaling pathways. This compound is particularly valuable in cancer research, as ILK is often implicated in tumor progression and metastasis. By inhibiting ILK, ILK-IN-1 helps in understanding the mechanisms of cancer cell survival and proliferation, potentially aiding in the development of targeted therapies. Additionally, it is used in studies related to tissue repair and fibrosis, where ILK signaling plays a critical role. Its application extends to exploring the impact of ILK inhibition on cardiovascular diseases, as ILK is known to influence cardiac function and vascular remodeling. Overall, ILK-IN-1 is a crucial tool for dissecting the biological functions of ILK and its potential as a therapeutic target.